Sort
39,280 grants matching “leukemia”
In vivo targeting of hematopoetic cells with glycan ligands of siglecs
$384,203James C. Paulson · Scripps Research Institute, The · R01 · FY2011 · CA
Molecular Genetic Changes in Leukemia in Infants
$384,200Children'S Hospital Of Philadelphia · R01 · FY2002 · CA
Role of a Novel Homeobox Transcription Factor (HLX) in Acute Myeloid Leukemia
$384,194Ulrich Steidl · Albert Einstein College Of Medicine, Inc · R01 · FY2017 · CA
Project 2: Defining and exploiting genetic dependencies in complex karyotype AML
$384,164Scott W Lowe · Sloan-Kettering Inst Can Research · P50 · FY2021 · CA
Project 1: Increasing therapeutic efficacy in isocitrate dehydrongenase (IDH)âmutant acute myeloid leukemia (AML)
$384,164Ross L Levine · Sloan-Kettering Inst Can Research · P50 · FY2021 · CA
Project 3: Therapeutic inhibition of splicing through inhibition of protein arginine methylation in leukemia
$384,164Omar Abdel-Wahab · Sloan-Kettering Inst Can Research · P50 · FY2021 · CA
Project 4: Chimeric Antigen Receptor T Cell Therapy for the Treatment of Acute Myeloid Leukemia
$384,163Renier Joseph Brentjens · Sloan-Kettering Inst Can Research · P50 · FY2021 · CA
Epidemiology of Infant Leukemia
$384,162University Of Minnesota Twin Cities · R01 · FY2004 · CA
Novel Mechanisms of C-Kit Regulation in Mast Cells
$384,150Reuben Kapur · Indiana University Indianapolis · R01 · FY2015 · HL
Hematological consequences of FLVCR, a cytoplasmic heme export protein
$384,150Janis L Abkowitz · University Of Washington · R01 · FY2015 · HL
SOLID STATE RADIATION CHEMISTRY OF DNA
$384,146University Of Rochester · R01 · FY2000 · CA
CPML - Project 3: Genome-wide Studies of Adverse Effects
$384,140Mary V. Relling · St. Jude Children'S Research Hospital · P50 · FY2016 · GM
CPML - Project 3: Genome-wide Studies of Adverse Effects
$384,126Mary V. Relling · St. Jude Children'S Research Hospital · P50 · FY2018 · GM
THYMOMA TYROSINE PROTEIN KINASE
$384,112Salk Institute For Biological Studies · R01 · FY2003 · CA
FLow Cytometric Detection of Malignant Cells in Body Fluids
$384,110Maryalice Stetler-Stevenson · Division Of Basic Sciences - Nci · ZIC · FY2009 · CA
Regulatory Roles of Agnoprotein in Biology of JC virus
$384,102Mahmut Safak · Temple Univ Of The Commonwealth · R01 · FY2017 · NS
Control of neural stem cells by the nascent cerebrospinal fluid
$384,089Maria Lehtinen · Boston Children'S Hospital · R01 · FY2014 · NS
Human Platelet Defects in Transcription Factor RUNX1 Haplodeficiency
$384,079A Koneti Rao · Temple Univ Of The Commonwealth · R01 · FY2013 · HL
Human Platelet Defects in Transcription Factor RUNX1 Haplodeficiency
$384,079A Koneti Rao · Temple Univ Of The Commonwealth · R01 · FY2016 · HL
FANCONI ANEMIA--HETEROGENEITY AND CARRIER DETECTION
$384,041Rockefeller University · R37 · FY2001 · HL
Molecular Analysis of Normal and Thalassemic DNA
$384,016Stuart H Orkin · Boston Children'S Hospital · R01 · FY2008 · HL
Molecular Analysis of Normal and Thalassemic DNA
$384,016Stuart H Orkin · Boston Children'S Hospital · R01 · FY2007 · HL
Glucocorticoids in Lymphoblastic Leukemia
$383,964Mary V. Relling · St. Jude Children'S Research Hospital · R01 · FY2012 · CA
GENE EXPRESSION PROFILE OF PROGRESSION &RESPONSE IN CML
$383,961Fred Hutchinson Cancer Research Center · U01 · FY2001 · CA
The chromatin remodeler Mi2 in T cell development
$383,926Katia Georgopoulos · Massachusetts General Hospital · R01 · FY2009 · AI